Indian Covid Vaccine Manufacturers

Prime Minister Narendra Modi met seven Indian COVID-19 vaccine manufacturers today, a meeting that comes in the wake of the country achieving the landmark of administering 100 crore doses of the jabs, official sources said.

Indian pharma major Wockhardt announced today that the company has signed a deal with Dubai's Enso Healthcare to make and supply doses of Russia's Sputnik V / Sputnik Light vaccine against COVID-19.

Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine and that it plans to manufacture up to 120 million doses of the shot annually.

Chief economic adviser has said that unemployment has gone up in India as Corona virus pandemic has had repercussions on jobs.

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application

The government's push to export coronavirus vaccines worldwide was today questioned by Rajya Sabha MP and Shiv Sena leader Priyanka Chaturvedi in a tweet as she asked: "Shouldn't Indians have equal access for vaccines manufactured in India?"

The US International Development Finance Corporation (DFC) has announced it will support Indian manufacturer Biological E's efforts to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022 with stringent regulatory authorization (SRA) and/or WHO Emergency Use listing including Johnson & Johnson vaccines.

Sri Lanka will purchase 2 to 3 million doses of Oxford-AstraZeneca vaccine from its Indian manufacturing company Serum Institute of India during the next two days, a top Sri Lankan official said on Wednesday.

Indian scientists and health warriors have risen to the occasion and the vaccines being developed and manufactured in India will help our people as well as humanity at large in escaping from the COVID-19 pandemic, Prime Minister Narendra Modi said in a message to Maldivian President Ibrahim Solih on Monday.

Preparations for administering the coronavirus vaccine on Indians are in the last stages, Prime Minister Narendra Modi said on Thursday, a day after government-appointed experts reviewed the emergency-use applications filed by three drugmakers.

Several Indian pharmaceutical companies are working to develop or manufacture at least eight anti-COVID-19 formulations as the world's largest producer of vaccines prepares for a massive response to the coronavirus pandemic.

The Serum Institute of India (SII) is ready to restart coronavirus vaccine trials - pending permission from the Drug Controller General of India (DGCI) - the manufacturer said in a statement on Saturday evening

In a significant development related to the COVID-19 vaccine, Russia has expressed its willingness to the Indian government for collaboration in the manufacturing of COVID vaccine - Sputnik V, a government official said on Tuesday.

Trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK.

Prime Minister Narendra Modi met seven Indian COVID-19 vaccine manufacturers today, a meeting that comes in the wake of the country achieving the landmark of administering 100 crore doses of the jabs, official sources said.

Indian pharma major Wockhardt announced today that the company has signed a deal with Dubai's Enso Healthcare to make and supply doses of Russia's Sputnik V / Sputnik Light vaccine against COVID-19.

Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine and that it plans to manufacture up to 120 million doses of the shot annually.

Chief economic adviser has said that unemployment has gone up in India as Corona virus pandemic has had repercussions on jobs.

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application

The government's push to export coronavirus vaccines worldwide was today questioned by Rajya Sabha MP and Shiv Sena leader Priyanka Chaturvedi in a tweet as she asked: "Shouldn't Indians have equal access for vaccines manufactured in India?"

The US International Development Finance Corporation (DFC) has announced it will support Indian manufacturer Biological E's efforts to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022 with stringent regulatory authorization (SRA) and/or WHO Emergency Use listing including Johnson & Johnson vaccines.

Sri Lanka will purchase 2 to 3 million doses of Oxford-AstraZeneca vaccine from its Indian manufacturing company Serum Institute of India during the next two days, a top Sri Lankan official said on Wednesday.

Indian scientists and health warriors have risen to the occasion and the vaccines being developed and manufactured in India will help our people as well as humanity at large in escaping from the COVID-19 pandemic, Prime Minister Narendra Modi said in a message to Maldivian President Ibrahim Solih on Monday.

Preparations for administering the coronavirus vaccine on Indians are in the last stages, Prime Minister Narendra Modi said on Thursday, a day after government-appointed experts reviewed the emergency-use applications filed by three drugmakers.

Several Indian pharmaceutical companies are working to develop or manufacture at least eight anti-COVID-19 formulations as the world's largest producer of vaccines prepares for a massive response to the coronavirus pandemic.

The Serum Institute of India (SII) is ready to restart coronavirus vaccine trials - pending permission from the Drug Controller General of India (DGCI) - the manufacturer said in a statement on Saturday evening

In a significant development related to the COVID-19 vaccine, Russia has expressed its willingness to the Indian government for collaboration in the manufacturing of COVID vaccine - Sputnik V, a government official said on Tuesday.

Trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK.